Iterum Therapeutics Files for Winding Up and Enters Provisional Liquidation

Iterum Therapeutics has officially filed a petition with the High Court in Ireland to initiate the winding-up process for the company. In response to the filing, the court has appointed Damien Murran and Jennifer McMahon of Teneo Restructuring as joint provisional liquidators. The company, which is currently listed on the Nasdaq under the ticker ITRM, is now operating under provisional liquidation status. This move typically signals that a company is no longer a going concern and is unable to meet its outstanding financial obligations. Such terminal events often result in a total loss for equity holders and lead to the eventual delisting of the stock from public exchanges. Investors are closely watching the liquidation proceedings to assess any potential recovery value for stakeholders.

Sources:globenewswire.comreuters.combloomberg.comfiercepharma.commarketwatch.comirishtimes.commanilatimes.nettaiwannews.com.twstocktitan.nettipranks.comintellectia.ai